SearchDictionaryMobileLogin

ECP regimen

Subscribe to Selected New Research on ECP regimen
3  relevant articles (0 outcomes, 2 trials/studies) found for this Bio-Agent

Description: chemotherapy regimen consisting of edatrexate, cyclophosphamide and cisplatin; used in treatment of non-small-cell lung cancer

Bio-Agent Context: Research Results

-
Therapeutics: 5215
-
Drug Therapy: 116820
-
Combination Drug Therapy: 8327
-
Antineoplastic Combined Chemotherapy Protocols: 16
*
ECP regimen: 3
-
Antineoplastic Protocols: 20
-
Antineoplastic Combined Chemotherapy Protocols: 16
*
ECP regimen: 3
-
Clinical Protocols
-
Antineoplastic Protocols: 20
-
Antineoplastic Combined Chemotherapy Protocols: 16
*
ECP regimen: 3
-
Heterocyclic Compounds: 23
-
2-Ring Heterocyclic Compounds
-
Pteridines: 30
-
Pterins: 38
-
Aminopterin: 222
*
ECP regimen: 3
-
Inorganic Chemicals: 5
-
Platinum Compounds: 255
-
Cisplatin: 19177
*
ECP regimen: 3
-
Nitrogen Compounds: 35
-
Cisplatin: 19177
*
ECP regimen: 3
-
Chlorine Compounds: 4
-
Cisplatin: 19177
*
ECP regimen: 3
-
Organic Chemicals: 40
-
Hydrocarbons: 382
-
Halogenated Hydrocarbons: 28
-
Mustard Compounds: 3
-
Nitrogen Mustard Compounds: 1
-
Phosphoramide Mustards: 3
-
Cyclophosphamide: 14977
*
ECP regimen: 3
-
Organophosphorus Compounds: 126
-
Phosphoramide Mustards: 3
-
Cyclophosphamide: 14977
*
ECP regimen: 3